Pfizer is taking a curtain call for Vyndaqel, the low-dose version of its blockbuster tafamidis franchise for the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM). | Pfizer is taking ...

The layoffs will affect employees at Pfizer’s Bothell, Washington site, which previously served as the headquarters for ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

The advancement of Pfizer’s antibody-drug conjugate portfolio has not spared the former Seagen site—and those who helped ...

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The biopharmaceutical company laid off 100 workers at its Bothell location on Monday, according to a notice filed with the ...

Pfizer stock trades at a multi-year low with a 6.65% dividend yield. Click here for a full investment analysis of PFE stock.

In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

Pfizer has been accused by the UK’s pharmaceutical watchdog of “bringing discredit” on the industry after senior executives used social media to promote an “unlicensed” Covid vaccine.